| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |
| 01/21/2004 | EP1381366A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 01/21/2004 | EP1282601B1 Process and intermediates for the preparation of 1-(9h-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol, carvedilol or acid addition salt thereof |
| 01/21/2004 | EP0935463B1 Use of anti-neurogenic inflammatory compounds and compositions |
| 01/21/2004 | CN1469739A Method for modulating bladder function |
| 01/21/2004 | CN1135228C N-aryloxyethyl-indoly-alkylamines for treatment of depression |
| 01/20/2004 | US6680335 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds |
| 01/20/2004 | US6680316 Pyridazin-3-one derivatives and medicines containing the same |
| 01/15/2004 | WO2004006355A2 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | WO2004006354A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | WO2004006352A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | WO2004005981A1 Filters for electronic displays |
| 01/15/2004 | WO2004005513A2 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 01/15/2004 | WO2004005406A2 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/15/2004 | WO2004005295A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 01/15/2004 | WO2004005288A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | WO2004005279A2 Substituted anthranilic amide derivatives and methods of use |
| 01/15/2004 | WO2004005278A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 01/15/2004 | WO2004005253A1 Indolin phenylsulfonamide derivatives |
| 01/15/2004 | WO2004005252A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | WO2004005251A1 Phenol derivatives and method of use thereof |
| 01/15/2004 | WO2004004729A1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases |
| 01/15/2004 | WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/15/2004 | WO2004004629A2 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | US20040010149 Ligand for transition metal complex catalyst |
| 01/15/2004 | US20040010148 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 01/15/2004 | US20040010103 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 01/15/2004 | US20040010029 Also benzothiophene derivatives; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and infections; modulating T helper cells, Th1/ Th2, and inhibiting the transcription of IL-4 |
| 01/15/2004 | US20040010012 Selective inhibitor of the biological activity of human osteoclast cells |
| 01/15/2004 | US20040006834 Such as 4-(5,6-dimethoxyindolin-1-yl)-phenylamine hydrochloride; hair dyes |
| 01/15/2004 | CA2492692A1 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | CA2492690A1 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | CA2492689A1 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | CA2492688A1 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | CA2492686A1 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/15/2004 | CA2492122A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 01/15/2004 | CA2492121A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | CA2491998A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | CA2491477A1 Indolin phenylsulfonamide derivatives |
| 01/15/2004 | CA2491127A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/15/2004 | CA2491020A1 Phenol derivatives and method of use thereof |
| 01/15/2004 | CA2490579A1 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 01/15/2004 | CA2489396A1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases |
| 01/15/2004 | CA2489166A1 Substituted anthranilic amide derivatives and methods of use |
| 01/15/2004 | CA2488816A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 01/14/2004 | EP1380568A2 Perfluoroalkylaniline derivatives |
| 01/14/2004 | EP1380562A1 Carboxylic acid derivative and salt thereof |
| 01/14/2004 | EP1379508A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 01/14/2004 | EP1379502A1 Nicotinic acetylcholine receptor ligands |
| 01/14/2004 | EP1379501A1 Indolinones, substituted in position 6, and their use as kinase inhibitors |
| 01/14/2004 | EP1379269A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 01/14/2004 | EP1379249A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 01/14/2004 | EP1379246A1 Nociceptin analogs |
| 01/14/2004 | EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/14/2004 | EP1095018B1 Aminoiminoquinone and aminoquinone alkaloid compounds as caspase inhibitors |
| 01/14/2004 | CN1468218A Processes for preparation of bicyclic compounds and intermediates therefor |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468110A Combinations of statins, estrogenic agents and optionally estrogens |
| 01/14/2004 | CN1134440C 4-oxo-3,5-dihydro-4H-pyridazino [4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/13/2004 | US6677418 Reacting activated strained mono(poly)cyclic olefin monofunctional monomer with strained di(poly)cyclic olefin difunctional monomer in presence of catalyst or initiator to form copolymer crosslinkable in presence of heat and catalyst |
| 01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677369 Antithrombotic agents |
| 01/13/2004 | US6677368 4-aryl substituted indolinones |
| 01/13/2004 | US6677367 Lysine derivative with 2-aminosulfonylthiophene substituent; acquired immunodeficiency syndrome (aids) viricides |
| 01/13/2004 | US6677365 Antagonists of MCP-1 function and methods of use thereof |
| 01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/08/2004 | WO2004003510A2 Fluorescent dyes, energy transfer couples and methods |
| 01/08/2004 | WO2004003037A1 Halogen substituted catalyst system for olefin polymerization |
| 01/08/2004 | WO2004003032A2 Heterocyclic nitrogen-containing activators and catalyst systems for olefin polymerization |
| 01/08/2004 | WO2004003031A2 Polymerization catalyst activators, method of preparing and their use in polymerization processes |
| 01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002472A1 Carvedilol hydrobromide |
| 01/08/2004 | WO2004002419A2 Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment |
| 01/08/2004 | WO2003093302A3 Process for the synthesis of peptides amides by side-chain attachement to a solid phase |
| 01/08/2004 | WO2003084928A8 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers |
| 01/08/2004 | WO2002059124A3 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 01/08/2004 | US20040006238 As chemical intermediates for production of pharmacologically useful oxazolidinones |
| 01/08/2004 | US20040006141 Amidocarboxylic acid compounds |
| 01/08/2004 | US20040006123 Interleukin-4 gene expression inhibitors |
| 01/08/2004 | US20040006096 Substituted alkanohydroxamic acids and method of reducing TNFalpha levels |
| 01/08/2004 | US20040006090 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| 01/08/2004 | US20040006088 Substituted N-(indole-2-carbonyl) -amides and derivatives as glycogen phosphorylase inhibitors |
| 01/08/2004 | US20040006084 For therapy and prophylaxis of inflammatory diseases, asthma |
| 01/08/2004 | US20040006080 Chemical compounds |
| 01/08/2004 | US20040006054 Cytotoxic N-unsubstituted indoles and cyclopent(b)indoles and method of making and using same |
| 01/08/2004 | US20040006050 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/08/2004 | US20040005984 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 01/08/2004 | US20040005983 New polymerization catalyst activators are disclosed which include a heterocyclic compound, which may or may not be substituted, and an aluminum alkyl or an aluminoxane. Supported activators of the invention include the heterocyclic |
| 01/08/2004 | DE10224844A1 Nicht-peptidische BRS-3-Agonisten Non-peptidic BRS-3 agonist |
| 01/08/2004 | CA2492084A1 Carvedilol hydobromide |
| 01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378246A1 Remedies for arteriosclerosis |